Investors / Switzerland / Debiopharm Innovation Fund
Debiopharm Innovation Fund
Corporate VC · Lausanne, Switzerland · Europe
Debiopharm Innovation Fund is the strategic corporate venture fund of Debiopharm, investing in startups that transform pharmaceutical R&D and cancer care. It provides financing along with strategic guidance, pharma expertise and network access to its portfolio companies.
Invests inHealthcare & Biotech
In its own wordsdigital healthoncologyaiclinical trialsdrug discoveryreal-world data
Your fit with Debiopharm Innovation Fund
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsDebiopharm Innovation Fund lists 24 checked portfolio companies on its own site and is named in 2 funding rounds. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (88%), AI & Machine Learning (4%) and Media & Entertainment (4%). 33% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, 14Peaks Capital and Agoranov.
Counts come from funding rounds that name Debiopharm Innovation Fund, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Debiopharm Innovation Fund's whole history. Rounds on record name 2 companies; its own site lists 24. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 0% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 2 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 59th | 24 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 73th | 50% of entries at pre-seed or seed |
| Evidence | 73th | 8% of companies confirmed by a round |
| Sector focus | 95th | 88% in its largest sector |
| Reach | 83th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 3 |
| 14Peaks Capital | 1 |
| Agoranov | 1 |
| Alven | 1 |
| Benchstrength | 1 |
| Boost Capital Partners | 1 |
| Connect Ventures | 1 |
| Continuum Health Ventures | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers2083%
- No longer answers00%
- Points to another company417%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 88% | 15% |
| AI & Machine Learning | 4% | 18% |
| Media & Entertainment | 4% | 4% |
| Education | 4% | 7% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Debiopharm Innovation Fund head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
as stated on its siteRecent portfolio activity
when companies last raised with Debiopharm Innovation Fund| Date | Company | Stage |
|---|---|---|
| 5 Oct 2026 | Series B | |
| 20 Apr 2026 | Seed |
Round details for Debiopharm Innovation Fund
Amounts, full round histories and every co-investor in Debiopharm Innovation Fund's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
24 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company's website appears to be a demonstration of a rich text editor. | Media & EntertainmentEducation | Portfolio page | ||
| BC Platforms brings together hard-to-access global data, AI-native technology, advanced analytics, governed access and federation, and scientific and technical expertise in one integrated evidence-generation solution. | Healthcare & Biotech | Portfolio page | ||
| Concr predicts response to cancer therapy for every patient using advanced analytics and technology | Healthcare & Biotech | Portfolio page | ||
| Genialis is a precision oncology company helping the most promising molecules become life-saving medicines | Healthcare & Biotech | Portfolio page | ||
| HopeAI brings together specialized AI agents, proprietary data, and validated workflows to transform how new medicines are developed. | Healthcare & Biotech | Portfolio page | ||
| Iktos leverages cutting-edge AI and robotics to transform drug discovery | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| MedaSystems provides a cloud platform for managing expanded and pre-approval access programs for life science companies | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| ModernVivo analyzes millions of peer-reviewed publications to help researchers identify relevant in vivo models and extract nuanced protocol conditions | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Octozi helps sponsors automate clinical data workflows using artificial intelligence. | Healthcare & Biotech | Portfolio page | ||
Healthcare & BiotechAI & Machine Learning | Portfolio page | |||
| Raidium develops and provides an artificial intelligence platform for radiology workflows | Healthcare & Biotech | Portfolio page | ||
| Risklick develops AI software to design and develop clinical trial protocols and study plans | Healthcare & Biotech | Portfolio page | ||
| Stitch stops no shows, improves compliance and ensures patients show up ready for clinical research sites with no manual work | Healthcare & Biotech | Portfolio page | ||
| StratifAI develops an AI platform that links histology, RNASeq, and patient outcomes to drive insights and discoveries in cancer biology | Healthcare & Biotech | Portfolio page | ||
| Tune Insight connects hospital and patient data across Europe into real-world evidence, without the data ever leaving the hospital. | Healthcare & Biotech | Portfolio page | ||
| VeriSIM Life drives the discovery, development, and commercialization of groundbreaking therapies through innovative science and AI-driven methods. | Healthcare & Biotech | Portfolio page | ||
| The company develops digital pathology technology to analyze tissue samples and provide quantitative biomarker data from routine H&E slides. | Healthcare & Biotech | Apr 2026Seed | Page + round |
About this data
site last read 8 Nov 2026- Site
- debiopharm.com
- Last read
- 8 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 20 Apr 2026
- Companies checked
- 24
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Debiopharm Innovation Fund's profile as data
Pull Debiopharm Innovation Fund's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/debiopharm.com
# also
GET /v1/firms/debiopharm.com/portfolio
GET /v1/firms/debiopharm.com/coinvestors
GET /v1/firms/debiopharm.com/news